Filters

CD19(Ser227) Antibody, ALEXA FLUOR 350

CD19(Ser227) Antibody, ALEXA FLUOR 350 size: 100ul 350

Price 350
Size 100ul
Long name ALEXA FLUOR 350 Conjugated, CD19(Ser227) Polyclonal Antibody
Also known asAnti-CD19 Ser227 PAb ALEXA FLUOR 350
CategoryConjugated Primary Antibodies
Conjugated with 350, ALEXA FLUOR®
Host OrganismRabbit (Oryctolagus cuniculus)
Target AntigenCD19 Ser227
SpecificityThis is a highly specific antibody against CD19 Ser227
ModificationPhosphorylation
Modification SiteSer227
ClonalityPolyclonal
ClonePolyclonal antibody
Concentration1ug per 1ul
Immunogen range200-250/556
Subcellular locationExtracellular
SourceKLH conjugated synthetic phosphopeptide derived from human CD19 around the phosphorylation site of Ser227 [LL(p-S)LE]
Gene ID Number930
Swiss ProtP15391
Tested applicationsIF(IHC-P)
Recommended dilutionsIF(IHC-P)(1:50-200)
CrossreactivityHuman
Cross-reactive species details not every possible cross-reactivity is known, Due to limited amount of testing and knowledge
Background of the antigenAssembles with the antigen receptor of B-lymphocytes in order to decrease the threshold for antigen receptor-dependent stimulation
PurificationPurified by Protein A
Storage conditions 50% glycerol and 0, Keep refrigerated at 2 to 8 degrees Celcius for up to one year, 09% sodium azide, Store this antibody in aqueous buffered solution containing 1% BSA
Excitation emission343nm/442nm
Properties ALEXA FLUOR they should be stored frozen at - 24°, Alexa Fluor 350 conjugates can be used in multi-color flow cytometry with FACS's equipped with a second red laser or red diode, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies, C, C for long term storage and for short term at + 5°, For facs or microscopy Alexa 1 conjugate
Conjugation ALEXA FLUOR 350, Alexa Fluor
Gene targetCD19(Ser227)
Short nameCD19(Ser227) Antibody
Technique antibodies against human proteins, antibodies for, Antibody
LabelALEXA FLUOR 350
Alternative name ALEXA FLUOR 350, CD19 molecule(Ser227) (Antibody to)
Alternative techniqueantibodies
Alternative to gene target B4 and CVID3, CD19 and IDBG-23791 and ENSG00000177455 and 930, CD19 and IDBG-638894 and ENSBTAG00000032122 and, Cd19 and IDBG-209475 and ENSMUSG00000030724 and 12478, Cell surfaces, protein binding, this GO :0005057 and receptor signaling protein activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0005887 and integral component of plasma membrane and cellular component this GO :0006968 and cellular defense response and biological process this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0007173 and epidermal growth factor receptor signaling pathway and biological process this GO :0008543 and fibroblast growth factor receptor signaling pathway and biological process this GO :0009897 and external side of plasma membrane and cellular component this GO :0038095 and Fc-epsilon receptor signaling pathway and biological process this GO :0045087 and innate immune response and biological process this GO :0048011 and neurotrophin TRK receptor signaling pathway and biological process this GO :0048015 and phosphatidylinositol-mediated signaling and biological process this GO :0050776 and regulation of immune response and biological process this GO :0050853 and B cell receptor signaling pathway and biological process this GO :0070062 and extracellular vesicular exosome and cellular component, this GO :0005057: receptor signaling protein activity, this GO :0005057: receptor signaling protein activity and also this GO :0005515: protein binding, this GO :0005515: protein binding, CD19 molecule
Identity 1633
Gene CD19
Long gene name CD19 molecule
Synonyms gene name CD19 antigen
Locus 16p11, 2
Discovery year 1991-06-04
Entrez gene record 930
Classification Immunoglobulin like domain containing CD molecules Minor histocompatibility antigens
Havana BLAST/BLAT OTTHUMG00000097049
Locus Specific Databases CD19base: Mutation registry for CD19 deficiency LRG_35

Subscribe to our Newsletter